PMN

PMN

USD

ProMIS Neurosciences Inc. Common Shares (ON)

$0.406-0.004 (-0.878%)

Prix en Temps Réel

Healthcare
Biotechnologie
Canada

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$0.410

Haut

$0.419

Bas

$0.401

Volume

0.28M

Fondamentaux de l'Entreprise

Capitalisation Boursière

21.9M

Industrie

Biotechnologie

Pays

Canada

Statistiques de Trading

Volume Moyen

1.51M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $0.38Actuel $0.406Haut $1.59

Actualités Connexes

GlobeNewswire

ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

Cambridge, Massachusetts, Nov. 03, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (NASDAQ:PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer's disease (AD) and other

Voir plus
ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
GlobeNewswire

ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group

Appointment reinforces ProMIS Neurosciences' strategic vision and deepens investor engagement as the Company advances its differentiated Alzheimer's program, PMN310 Cambridge, Massachusetts, Oct. 22, 2025 (GLOBE

Voir plus
ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.